top of page
Pulp Fixin™


Cold Chain, Hot Problem: Why It’s Time to Move Beyond Styrofoam
From life-saving biologics to on-demand pharmaceuticals delivered to your doorstep, the cold chain has become one of the most critical infrastructures in modern healthcare. But behind every temperature-controlled shipment lies a growing problem no one talks about enough: Styrofoam is everywhere. The Hidden Cost of Keeping Things Cold Cold chain logistics in life sciences is expanding rapidly. With the rise of personalized medicine, direct-to-patient delivery models, and globa
3 min read


What’s Next for Cold Chain in Biotech and Pharma? Expect the Styrofoam Crackdown.
As the global demand for biologics, mRNA therapies, and temperature-sensitive pharmaceuticals accelerates, the cold chain infrastructure that supports them is under increasing scrutiny—not just for performance, but for environmental impact. While 2026 promises smarter systems, tighter regulations, and expanded global distribution, there’s one constant still clinging to the supply chain: Styrofoam. 📦 The Problem with Performance—Isn’t Performance Expanded polystyrene (EPS), k
2 min read
bottom of page
